1. Home
  2. CODX vs ALUR Comparison

CODX vs ALUR Comparison

Compare CODX & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • ALUR
  • Stock Information
  • Founded
  • CODX 2013
  • ALUR 2009
  • Country
  • CODX United States
  • ALUR United States
  • Employees
  • CODX N/A
  • ALUR N/A
  • Industry
  • CODX Medical/Dental Instruments
  • ALUR
  • Sector
  • CODX Health Care
  • ALUR
  • Exchange
  • CODX Nasdaq
  • ALUR Nasdaq
  • Market Cap
  • CODX 22.0M
  • ALUR 19.1M
  • IPO Year
  • CODX 2017
  • ALUR N/A
  • Fundamental
  • Price
  • CODX $0.36
  • ALUR $3.35
  • Analyst Decision
  • CODX Hold
  • ALUR Strong Buy
  • Analyst Count
  • CODX 1
  • ALUR 3
  • Target Price
  • CODX $1.00
  • ALUR $22.83
  • AVG Volume (30 Days)
  • CODX 273.0K
  • ALUR 4.1M
  • Earning Date
  • CODX 03-27-2025
  • ALUR 03-26-2025
  • Dividend Yield
  • CODX N/A
  • ALUR N/A
  • EPS Growth
  • CODX N/A
  • ALUR N/A
  • EPS
  • CODX N/A
  • ALUR N/A
  • Revenue
  • CODX $3,915,160.00
  • ALUR $32,110,000.00
  • Revenue This Year
  • CODX N/A
  • ALUR $2.18
  • Revenue Next Year
  • CODX N/A
  • ALUR $35.85
  • P/E Ratio
  • CODX N/A
  • ALUR N/A
  • Revenue Growth
  • CODX N/A
  • ALUR N/A
  • 52 Week Low
  • CODX $0.28
  • ALUR $2.15
  • 52 Week High
  • CODX $2.23
  • ALUR $98.75
  • Technical
  • Relative Strength Index (RSI)
  • CODX 32.41
  • ALUR 51.19
  • Support Level
  • CODX $0.28
  • ALUR $2.72
  • Resistance Level
  • CODX $0.50
  • ALUR $3.50
  • Average True Range (ATR)
  • CODX 0.06
  • ALUR 0.40
  • MACD
  • CODX -0.01
  • ALUR 0.18
  • Stochastic Oscillator
  • CODX 27.86
  • ALUR 56.99

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: